More Immunotech Biopharm Ltd news
Immunotech Biopharm LtdHKEX: 6978

Supplemental announcement to the annual report for the year ended 31 december 2025

Sep 30, 2026 at 10:30 AM UTC · Issued by Immunotech Biopharm Ltd via HKEXnews

HKEX: 6978

View Attachment

View original source (HKEXnews)

Earlier from Immunotech Biopharm

  • Immunotech Biopharm: MAJOR TRANSACTION FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASED IN BEIJINGMay 13, 2021
  • Immunotech Biopharm: CHANGE OF SENIOR MANAGEMENTApr 13, 2021
  • Immunotech Biopharm: MAJOR TRANSACTION CONSTRUCTION AGREEMENT IN RELATION TO THE CONSTRUCTION OF THE NEW BIOLOGICAL DRUG R&D AND INDUSTRIALISATION BASE IN BEIJINGMar 29, 2021
  • Immunotech Biopharm: VOLUNTARY ANNOUNCEMENT ESTABLISHMENT OF AND INVESTMENT IN CELLULAR IMMUNOTHERAPY SPECIALISED INDUSTRY FUND AS A LIMITED PARTNERFeb 24, 2021
All Immunotech Biopharm news releases↗